Prof. Peter Seeberger

Prof. Dr. Peter H. Seeberger
Laboratorium für Organische Chemie
ETH Hönggerberg / HCI F 315
Wolfgang-Pauli-Strasse 10
CH-8093 Zürich
Switzerland
Phone: +41 44 633 21 03
Email: seeberger@org.chem.ethz.ch

Peter H. Seeberger (b. 1966) received his B.S. in 1989 from the Universität Erlangen-Nürnberg, where he studied chemistry as a Bavarian government fellow. In 1990 he moved as a Fulbright scholar to the University of Colorado where he earned his Ph.D. in biochemistry under the guidance of Marvin H. Caruthers in 1995. After a postdoctoral fellowship with Samuel J. Danishefsky at the Sloan-Kettering Institute for Cancer Research in New York City he began his independent career at the Massachusetts Institute of Technology in January 1998 and was promoted to Firmenich Associate Professor of Chemistry in 2002. In June 2003 he assumed a position as Professor for Organic Chemistry at the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland and a position as Affiliate Professor at the Burnham Institute in La Jolla, CA. His research interests focus on the interface of chemistry and biology and in particular on the role of complex carbohydrates and glycoconjugates in information transfer in biological systems. His group has developed new methods for the automated solid-phase synthesis of complex carbohydrates and glycosaminoglycans that serve as molecular tools. Other interests include synthetic methodology, total synthesis, immunology, and biochemical and biophysical studies of carbohydrates.

Among other awards he received the Technology Review Top 100 Young Innovator Award (1999), Edgerton Award (2002), an Arthur C. Cope Young Scholar Award from the American Chemical Society (2003), the Horace B. Isbell Award from the American Chemical Society (2003) and the Otto-Klung Weberbank Prize (2004).

Professor Seeberger is the Editor of the Journal of Carbohydrate Chemistry, Associate Editor of Chemistry & Biology and serves on the editorial advisory boards of several other journals. He serves of as member of the board of the Tesfa-Ilg "Hope for Africa" Foundation and the "Run-Against Malaria" event in Zurich. He is a consultant to several companies and the co-founder of Ancora Pharmaceuticals (Medford, USA).

CV (pdf)